Error: Could not add to watchlist. X
+ Watchlist

Trillium Therapeutics Inc

TRIL:CN
Toronto
5.72
CAD
0.03
0.52%
As of 3:36 PM EDT 6/27/2017
Open
5.75
Day Range
5.70 - 5.87
Volume
5,710
Previous Close
5.75
52Wk Range
5.70 - 23.48
1 Yr Return
-50.26%
Before it's here, it's on the Bloomberg Terminal.
Learn More
Open
5.75
Day Range
5.70 - 5.87
Volume
5,710
Previous Close
5.75
52Wk Range
5.70 - 23.48
1 Yr Return
-50.26%
YTD Return
-24.84%
Current P/E Ratio (TTM)
-
Earnings per Share (CAD) (TTM)
-6.51
Market Cap (m CAD)
60.604
Shares Outstanding (m)
10.595
Price/Sales (TTM)
-
Dividend Indicated Gross Yield
-
Sector
Health Care
% Price Change
-0.92%
% Price Change
-1.22%

Related Videos

There are currently no related videos for this ticker. Please check back later.
Profile
Trillium Therapeutics Inc. is a clinical stage immuno-oncology company. The Company develops therapies for the treatment of cancer and has preclinical programs, targeting the immunoregulatory pathways that tumor cells exploit to evade the host immune system.
Address
2488 Dunwin Drive
Mississauga, ON L5L 1J9
Canada
Phone
416-595-0627
  • Niclas Stiernholm
    President/CEO
  • James T Parsons
    Chief Financial Officer
  • Eric L Sievers
    Chief Medical Officer
  • Robert Uger "Bob"
    Chief Scientific Officer
  • Penka Petrova
    Chief Development Officer
Show More